Boopathy GTK, Hong W (2019) Role of Hippo Pathway-YAP/TAZ signaling in angiogenesis. Front Cell Dev Biol 7:49

Article  PubMed  PubMed Central  Google Scholar 

Cunningham R, Hansen CG (2022) The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer. Clin Sci 136(3):197–222

Article  CAS  Google Scholar 

de Oliveira MG, Nadruz W Jr., Mónica FZ (2022) Endothelial and vascular smooth muscle dysfunction in hypertension. Biochem Pharmacol 205:115263

Article  PubMed  Google Scholar 

Dong ZC, Wu MM, Zhang YL, Wang QS, Liang C, Yan X et al (2021) The vascular endothelial growth factor trap Aflibercept induces vascular dysfunction and hypertension via Attenuation of eNOS/NO signaling in mice. Acta Pharmacol Sin 42(9):1437–1448

Article  CAS  PubMed  Google Scholar 

Duiyimuhan G, Maimaiti N (2023) The association between atherogenic index of plasma and all-cause mortality and cardiovascular disease-specific mortality in hypertension patients: a retrospective cohort study of NHANES. BMC Cardiovasc Disord 23(1):452

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fan Q, Cai Q, Xu Y (2015) FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer. Oncotarget 6(29):27688–27699

Article  PubMed  PubMed Central  Google Scholar 

Filler G, Díaz González de Ferris ME (2024) Paediatric blood pressure percentiles from united States of America electronic health records. EBioMedicine 99:104913

Article  PubMed  Google Scholar 

Franco C, Sciatti E, Favero G, Bonomini F, Vizzardi E, Rezzani R (2022) Essential hypertension and oxidative stress: novel future perspectives. Int J Mol Sci 23(22):14489

Article  CAS  PubMed  PubMed Central  Google Scholar 

Harrison DG, Coffman TM, Wilcox CS (2021) Pathophysiology of hypertension: the mosaic theory and beyond. Circ Res 128(7):847–863

Article  CAS  PubMed  PubMed Central  Google Scholar 

Humphrey JD (2021) Mechanisms of vascular remodeling in hypertension. Am J Hypertens 34(5):432–441

Article  PubMed  Google Scholar 

Ibar C, Irvine KD (2020) Integration of Hippo-YAP signaling with metabolism. Dev Cell 54(2):256–267

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kanbay M, Copur S, Tanriover C, Ucku D, Laffin L (2023) Future treatments in hypertension: can we meet the unmet needs of patients? Eur J Intern Med 115:18–28

Article  PubMed  Google Scholar 

Kostov K (2021) The causal relationship between endothelin-1 and hypertension: focusing on endothelial dysfunction, arterial stiffness, vascular remodeling, and blood pressure regulation. Life (Basel) 11(9):986

Article  CAS  PubMed  PubMed Central  Google Scholar 

Louca P, Tran TQB, Toit CD, Christofidou P, Spector TD, Mangino M et al (2022) Machine learning integration of multimodal data identifies key features of blood pressure regulation. EBioMedicine 84:104243

Article  PubMed  PubMed Central  Google Scholar 

Lv H, Ai D (2022) Hippo/yes-associated protein signaling functions as a mechanotransducer in regulating vascular homeostasis. J Mol Cell Cardiol 162:158–165

Article  CAS  PubMed  Google Scholar 

Ma S, Meng Z, Chen R, Guan KL (2019) The Hippo pathway: biology and pathophysiology. Annu Rev Biochem 88:577–604

Article  CAS  PubMed  Google Scholar 

Mia MM, Singh MK (2022) New insights into Hippo/YAP signaling in fibrotic diseases. Cells 11(13):2065

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moya IM, Halder G (2019) Hippo-YAP/TAZ signalling in organ regeneration and regenerative medicine. Nat Rev Mol Cell Biol 20(4):211–226

Article  CAS  PubMed  Google Scholar 

Müderrisoglu AE, Sakul AA, Murgas S, de la Rosette J, Michel MC (2023) Association of diabetes, hypertension, and their combination with basal symptoms and treatment responses in overactive bladder patients. Front Pharmacol 14:1144470

Article  PubMed  PubMed Central  Google Scholar 

Nilsson MB, Sun H, Robichaux J, Pfeifer M, McDermott U, Travers J et al (2020) A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components. Sci Transl Med 12(559):eaaz4589

Article  CAS  PubMed  PubMed Central  Google Scholar 

Panciera T, Azzolin L, Cordenonsi M, Piccolo S (2017) Mechanobiology of YAP and TAZ in physiology and disease. Nat Rev Mol Cell Biol 18(12):758–770

Article  CAS  PubMed  PubMed Central  Google Scholar 

Park JA, Kwon YG (2018) Hippo-YAP/TAZ signaling in angiogenesis. BMB Rep 51(3):157–162

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reel PS, Reel S, van Kralingen JC, Langton K, Lang K, Erlic Z et al (2022) Machine learning for classification of hypertension subtypes using multi-omics: a multi-centre, retrospective, data-driven study. EBioMedicine 84:104276

Article  PubMed  PubMed Central  Google Scholar 

Roy ME, Veilleux C, Paquin A, Gagnon A, Annabi B (2024) Transcriptional regulation of CYR61 and CTGF by LM98: a synthetic YAP-TEAD inhibitor that targets in-vitro vasculogenic mimicry in glioblastoma cells. Anticancer Drugs 35(8):709–719

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shi N, Chen SY (2014) Mechanisms simultaneously regulate smooth muscle proliferation and differentiation. J Biomed Res 28(1):40–46

Article  CAS  PubMed  Google Scholar 

Shimamura K, Zhou M, Ito Y, Kimura S, Zou LB, Sekiguchi F et al (2002) Effects of flufenamic acid on smooth muscle of the carotid artery isolated from spontaneously hypertensive rats. J Smooth Muscle Res 38(1–2):39–50

Article  CAS  PubMed  Google Scholar 

Sun HJ, Liu TY, Zhang F, Xiong XQ, Wang JJ, Chen Q et al (2015) Salusin-β contributes to vascular remodeling associated with hypertension via promoting vascular smooth muscle cell proliferation and vascular fibrosis. Biochim Biophys Acta 1852(9):1709–1718

Article  CAS  PubMed  Google Scholar 

Sun HJ, Ren XS, Xiong XQ, Chen YZ, Zhao MX, Wang JJ et al (2017) NLRP3 inflammasome activation contributes to VSMC phenotypic transformation and proliferation in hypertension. Cell Death Dis 8(10):e3074

Article  PubMed  PubMed Central  Google Scholar 

Totaro A, Panciera T, Piccolo S (2018) YAP/TAZ upstream signals and downstream responses. Nat Cell Biol 20(8):888–899

Article  CAS  PubMed  PubMed Central  Google Scholar 

Touyz RM, Alves-Lopes R, Rios FJ, Camargo LL, Anagnostopoulou A, Arner A et al (2018) Vascular smooth muscle contraction in hypertension. Cardiovasc Res 114(4):529–539

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ustiyan V, Wang IC, Ren X, Zhang Y, Snyder J, Xu Y et al (2009) Forkhead box M1 transcriptional factor is required for smooth muscle cells during embryonic development of blood vessels and esophagus. Dev Biol 336(2):266–279